TBCRC 048 (olaparib expanded) expansion cohorts: Phase 2 study of olaparib monotherapy in patients (pts) with metastatic breast cancer (MBC) with germline (g) mutations in PALB2 or somatic (s) mutations in BRCA1 or BRCA2 Meeting Abstract
| Authors: | Tung, N. M.; Robson, M. E.; Nanda, R.; Li, T.; Vinayak, S.; Shah, P. D.; Khoury, K.; Kimmick, G. G.; Santa-Maria, C. A.; Brufsky, A.; Demeo, M.; Vieira, J. P.; Carey, L. A.; Wulf, G. M.; Domchek, S. M.; Krop, I. E.; Wolff, A. C.; Winer, E. P.; Garber, J. E. |
| Abstract Title: | TBCRC 048 (olaparib expanded) expansion cohorts: Phase 2 study of olaparib monotherapy in patients (pts) with metastatic breast cancer (MBC) with germline (g) mutations in PALB2 or somatic (s) mutations in BRCA1 or BRCA2 |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557400131 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.1021 |
| Notes: | Meeting Abstract: 1021 -- Source: Wos |
